These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands. Ali A; Reddy GS; Cao H; Anjum SG; Nalam MN; Schiffer CA; Rana TM J Med Chem; 2006 Dec; 49(25):7342-56. PubMed ID: 17149864 [TBL] [Abstract][Full Text] [Related]
43. Total synthesis and biological evaluation of (-)-apicularen A and its analogues. Palimkar SS; Uenishi J; Ii H J Org Chem; 2012 Jan; 77(1):388-99. PubMed ID: 22118352 [TBL] [Abstract][Full Text] [Related]
44. In situ evaluation of kinetic resolution catalysts for nitroaldol by rationally designed fluorescence probe. Matsumoto T; Urano Y; Takahashi Y; Mori Y; Terai T; Nagano T J Org Chem; 2011 May; 76(10):3616-25. PubMed ID: 21370849 [TBL] [Abstract][Full Text] [Related]
45. Chiral N-heterocyclic carbene catalyzed staudinger reaction of ketenes with imines: highly enantioselective synthesis of N-Boc beta-lactams. Zhang YR; He L; Wu X; Shao PL; Ye S Org Lett; 2008 Jan; 10(2):277-80. PubMed ID: 18085789 [TBL] [Abstract][Full Text] [Related]
46. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance. Ghosh AK; Chapsal BD; Weber IT; Mitsuya H Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874 [TBL] [Abstract][Full Text] [Related]
47. Highly efficient asymmetric Michael addition of aldehyde to nitroolefin using perhydroindolic acid as a chiral organocatalyst. Zhao L; Shen J; Liu D; Liu Y; Zhang W Org Biomol Chem; 2012 Apr; 10(14):2840-6. PubMed ID: 22388774 [TBL] [Abstract][Full Text] [Related]
48. Synthesis of 7-azabicyclo[2.2.1]heptane and 2-oxa-4-azabicyclo[3.3.1]non-3-ene derivatives by base-promoted heterocyclization of alkyl N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)carbamates and N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)-2,2,2-trifluoroacetamides. Gómez-Sanchez E; Soriano E; Marco-Contelles J J Org Chem; 2007 Nov; 72(23):8656-70. PubMed ID: 17927252 [TBL] [Abstract][Full Text] [Related]
49. A designer axially chiral amino sulfonamide as an efficient organocatalyst for direct asymmetric mannich reactions of N-Boc-protected imines. Kano T; Yamaguchi Y; Maruoka K Angew Chem Int Ed Engl; 2009; 48(10):1838-40. PubMed ID: 19173354 [TBL] [Abstract][Full Text] [Related]
50. A process in need is a process indeed: scalable enantioselective synthesis of chiral compounds for the pharmaceutical industry. Ikunaka M Chemistry; 2003 Jan; 9(2):378-88. PubMed ID: 12532286 [TBL] [Abstract][Full Text] [Related]
51. Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors (II). Hohlfeld K; Wegner JK; Kesteleyn B; Linclau B; Unge J J Med Chem; 2015 May; 58(9):4029-38. PubMed ID: 25897791 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and structural characterization of pincer type bicyclic diacyloxy- and diazaselenuranes. Selvakumar K; Singh HB; Goel N; Singh UP; Butcher RJ Dalton Trans; 2011 Oct; 40(38):9858-67. PubMed ID: 21850325 [TBL] [Abstract][Full Text] [Related]
53. Asymmetric One-Pot Synthesis of (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol: A Key Component of Current HIV Protease Inhibitors. Sevenich A; Liu GQ; Arduengo AJ; Gupton BF; Opatz T J Org Chem; 2017 Jan; 82(2):1218-1223. PubMed ID: 27997193 [TBL] [Abstract][Full Text] [Related]